Anoro Ellipta 55/22 Inhalation Guide for COPD
Quick summary: Anoro Ellipta 55 micrograms/22 micrograms inhalation is a once-daily inhaler used for COPD maintenance treatment. It contains umeclidinium and vilanterol, which help keep the airways open and support easier breathing over time....
This content is for educational purposes only and does not replace medical advice, diagnosis or treatment from a qualified healthcare professional.
Quick summary: Anoro Ellipta 55 micrograms/22 micrograms inhalation is a once-daily inhaler used for COPD maintenance treatment. It contains umeclidinium and vilanterol, which help keep the airways open and support easier breathing over time.
This guide explains how it is used, what side effects are mentioned in the original content, and what to check with a doctor, pharmacist, or the official patient leaflet.
Medical disclaimer: This article is for general information only and does not replace advice from a qualified healthcare professional. Always follow the instructions supplied with your inhaler and the guidance given by your prescriber or pharmacist.
What is Anoro Ellipta 55 micrograms/22 micrograms inhalation?
Anoro Ellipta is an inhaled medicine used for chronic obstructive pulmonary disease (COPD). It combines two active ingredients, umeclidinium and vilanterol, in one device.
The original content describes it as a treatment designed to improve breathing and reduce flare-ups over time. It is used as a maintenance inhaler, not as a rescue inhaler for sudden breathing problems.
How Anoro Ellipta works
The two ingredients work together to help keep the airways open:
- Umeclidinium is a long-acting muscarinic antagonist (LAMA).
- Vilanterol is a long-acting beta-agonist (LABA).
According to the original content, this combination helps relax the muscles in the airways, making breathing easier and supporting longer-term symptom control in COPD.
How to use Anoro Ellipta
Correct inhaler technique matters because it helps ensure the dose is delivered properly. The original content gives these basic steps:
- Open the cover of the inhaler until you hear a click.
- Exhale fully, away from the inhaler.
- Place the mouthpiece in your mouth and inhale deeply and slowly.
- Remove the inhaler from your mouth and hold your breath for about 10 seconds.
- Close the inhaler after use to help protect it from moisture.
It also states that the inhaler is generally taken once daily and at the same time each day to help build a routine.
If you are unsure whether your inhaler technique is correct, check the patient leaflet or ask a pharmacist to demonstrate the steps.
When is the best time to take it?
The original content says Anoro Ellipta is usually taken once daily, and that many people choose the morning. A consistent time each day may help with routine use.
If a dose is missed, the original content advises taking it when remembered unless it is close to the next dose. It also says not to double dose.
Possible side effects and risks
Like all medicines, Anoro Ellipta may cause side effects in some people. The original content lists the following common effects:
- Dry mouth or throat
- Headache
- Coughing
- Nausea
- Increased heart rate
It also notes that more serious reactions can happen. The original content highlights the need for urgent medical help if there is:
- Difficulty breathing
- Swelling of the face or throat
- Chest pain
Any new or worrying symptom should be discussed with a healthcare professional.
What to know before using Anoro Ellipta
The original content advises telling a healthcare provider about any pre-existing conditions or allergies before starting treatment. This helps the prescriber assess whether the inhaler is suitable for the individual.
It is also important to read the official patient leaflet, because it contains the most complete instructions for use and safety information for the specific product pack.
What happens if you stop taking it?
According to the original content, stopping Anoro Ellipta without professional guidance may lead to a return of COPD symptoms, including increased shortness of breath and worsening control of the condition.
The article also states that Anoro Ellipta is not a rescue inhaler and should not be used for immediate relief of sudden breathing problems.
Why might Anoro Ellipta be expensive?
The original content says the cost may be influenced by research and development, manufacturing, and marketing costs, and that it is a branded medicine rather than a generic product.
If cost is a concern, the original content suggests speaking with a healthcare provider about possible support options.
How it fits into COPD care
Anoro Ellipta is described in the original content as a long-term treatment for COPD symptoms. It is presented as part of ongoing management rather than a one-time treatment.
People with COPD often need a treatment plan that is reviewed over time. A doctor or pharmacist can help confirm how this inhaler fits with the rest of the prescribed regimen.
Safety reminder
Do not use this inhaler for sudden breathing attacks unless a clinician has specifically told you to do so. If symptoms worsen, or if you have chest pain, swelling, or severe breathing difficulty, seek urgent medical help.
Frequently asked questions
▸ What is Anoro Ellipta 55/22 used for?
The original content says it is used for the long-term treatment of COPD symptoms, helping improve breathing and reduce flare-ups.
▸ How quickly does Anoro Ellipta work?
The original content says some people may notice improvement within a few hours, while the full effect may take several days to weeks.
▸ What stage of COPD is it used for?
The original content says it is typically prescribed for moderate to severe COPD, depending on the person’s symptoms and test results.
▸ What are the most common side effects?
The original content lists dry mouth, headache, cough, nausea, and increased heart rate as common side effects.
▸ Is Anoro Ellipta a rescue inhaler?
No. The original content states that it is not a rescue inhaler and should not be used for sudden breathing problems.
▸ What should I check in the leaflet?
Check the official instructions for inhaler technique, missed-dose advice, safety warnings, and any product-specific details.
Final note
If you use Anoro Ellipta, the most reliable source for personal guidance is your prescriber, pharmacist, and the official patient leaflet that comes with the inhaler. This article summarizes the original content and helps you understand the main points more clearly.
Medical disclaimer
This content is for educational purposes only. It should not be used as a substitute for professional medical advice, diagnosis or treatment. Always ask a doctor, pharmacist or qualified healthcare professional before starting, stopping or changing any medicine.
Sources and verification
The following sources or official references are listed to support verification of the medicine information discussed in this article.
- NHS: COPD inhalers
- MedlinePlus: Umeclidinium and Vilanterol Inhalation
- Electronic Medicines Compendium: Anoro Ellipta Patient Information Leaflet
- GSK: Anoro Ellipta product information
To improve this article with specific references, add a custom field named _aio_sources in the post editor and write one source per line using: Source title|Source URL.
Medicine information can change and may vary depending on country, product formulation, patient history and professional guidance. Always check official medicine information and ask a healthcare professional for personal medical questions.